De-escalation of Axillary Surgery After Neoadjuvant Therapy.
Clin Breast Cancer
; 24(5): 385-391, 2024 Jul.
Article
in En
| MEDLINE
| ID: mdl-38735808
ABSTRACT
Surgical de-escalation of the axilla has evolved over the past 28 years since the emergence of sentinel lymph node surgery. Well-documented complications of the once standard of care axillary lymph node dissection (ALND), including lymphedema, led physician scientists towards a progressive push to study and incorporate less invasive techniques in the axilla. Many trials have justified oncologic safety of axillary de-escalation in patients who are spared neoadjuvant treatment. The applicability in the neoadjuvant setting, however, is less clear and axillary surgical approaches in this patient population have evolved at a slower pace. This review aims to analyze current data in axillary management for patients undergoing neoadjuvant treatment and to discuss current surgical approaches based on nodal pathologic response.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Axilla
/
Breast Neoplasms
/
Neoadjuvant Therapy
/
Sentinel Lymph Node Biopsy
/
Lymph Node Excision
Limits:
Female
/
Humans
Language:
En
Journal:
Clin Breast Cancer
Journal subject:
NEOPLASIAS
Year:
2024
Document type:
Article
Country of publication:
United States